🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge
Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Post-Translational Modifications of Histone Variants in the Absence and Presence of a Methionine-Depleting Enzyme in Normal and Cancer Cells

Cancers(2023)10.3390/cancers15020527Source: DataRank Database

Post-Translational Modifications of Histone Variants in the Absence and Presence of a Methionine-Depleting Enzyme in Normal and Cancer Cells is a research paper published in Cancers (2023). On theSindex it has a DataRank of 0. It has been cited 9 times.

N/A
0DataRank · unranked

Scored on demand from live citation data

Open Access9 citations
Download PDF
Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring
Enrichment:Funding (2 grants)Impact (FWCI 0.82)OA: goldTopics (37)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)
Findable (1/2)
  • Has DOI
Accessible (1/2)
  • Open Access
Interoperable (0/2)
    Reusable (0/3)

      FAIR checklist signals are shown for context only and do not affect DataRank scoring.

      Run a calibrated FAIR evaluation for this paper →

      We only score data papers we can read in full — never from an abstract alone.

      Authors (6)

      Samanta RaboniORCID,Simone SidoliORCID,Andrea MozzarelliORCID,Stefano BettatiORCID,Annamaria BuschiniORCID
      Live enrichment
      PubMed:36672476PMC:PMC9857184OpenAlex:https://openalex.org/W4316467776

      National Institutes of Health

      Grant: 3P30CA013330-39S3

      Core Support for Cancer Center

      National Institutes of Health

      Grant: 1S10OD030286-01

      Orbitrap Exploris 480 Basic System

      FWCI

      0.82

      Citation Percentile

      0.7%

      Citation Trend

      2023
      2024
      2026

      goldLicense: cc-by
      journalhttps://www.mdpi.com/2072-6694/15/2/527/pdf?version=1673767780
      GOLDhttps://www.mdpi.com/2072-6694/15/2/527/pdf?version=1673767780
      publisherhttps://www.mdpi.com/2072-6694/15/2/527/pdf?version=1673767780
      publisherhttps://www.mdpi.com/2072-6694/15/2/527/pdf
      journalhttps://doi.org/10.3390/cancers15020527

      Fields of Study

      Epigenetics and DNA MethylationCancer Research and TreatmentsAmino Acid Enzymes and MetabolismMedicineBiology0301 basic medicine03 medical and health sciences

      Keywords

      MethionineHistoneMethylationBiochemistryMethyltransferaseHistone H3AcetylationCancer cellChemistryEnzymeEpigeneticsAmino acidCancerBiologyDNAGeneticsGeneMass spectrometryHT-29 Cell LineHistone VariantsMethionine Gamma-lyaseMethionine DepletionHs27 Cell Linehistone variant570histone variants; Hs27 cell line; HT-29 cell line; mass spectrometry; methionine depletion; methionine gamma-lyase610Articlemethionine depletion; histone variants; HT-29 cell line; Hs27 cell line; methionine gamma-lyasemass; spectrometryHT-29 cell line; Hs27 cell line; histone variants; mass spectrometry; methionine depletion; methionine gamma-lyase

      Sustainable Development Goals

      SDG 3: 3. Good healthSDG 0: Good health and well-being